Navigation Links
MacroGenics Acquires Raven Biotechnologies
Date:7/17/2008

Raven's Discovery Platform in Cancer Stem Cell Biology Enhances MacroGenics' Oncology Capabilities and Complements Proprietary Antibody

Technology Platforms

ROCKVILLE, Md., July 17 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the acquisition of Raven Biotechnologies, Inc., a privately held biotechnology company in South San Francisco, California, focused on the discovery and development of monoclonal antibody therapeutics for oncology through its cancer stem cell program.

Raven has developed a portfolio of proprietary cancer stem cells from many types of primary tumors. These cancer stem cells are maintained in vitro, and small numbers of these cells can form both localized and metastatic tumors in vivo. Using its proprietary technology platform, Raven has generated more than 1,300 monoclonal antibodies, including many that target cancer stem cells and cancers of the lung, colon, pancreas, prostate, breast and ovary.

"Raven's discovery platform in cancer stem cell biology is highly complementary to MacroGenics' proprietary Fc-optimization and next-generation antibody platforms," said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. "We believe that this acquisition provides MacroGenics with critical mass in oncology discovery, which is one of the most scientifically and commercially promising areas of drug development. With our internal capabilities in development and manufacturing, this transaction should result in the rapid production of new lead therapeutic candidates and increase the probability of clinical and commercial success. Moreover, with the wealth of these assets, we will expand our pursuit of collaborations and other strategic alliances with pharmaceutical and biotechnology companies."

"We are pleased that Raven's cancer stem cell ant
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
2. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
3. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
4. Neogen Acquires Product Line From DuPont Animal Health Solutions
5. Decision Resources, Inc. Acquires Manhattan Research
6. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
7. Miltenyi Biotec GmbH Acquires Medic Tools AG
8. Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI-COR Biosciences
9. Touch Bionics acquires LIVINGSKIN
10. Beckman Coulter Acquires Rights to Hepatitis C Virus
11. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... A key lawmaker who often disagrees with Governor Jim ... saw nothing inappropriate about the governor's use of an executive ... cell companies. , ,Meanwhile, the executive order, signed Tuesday at ... the director of Pro Life Wisconsin. , ,Ted Kanavas, R-Brookfield, ...
... GE Healthcare has received federal approval for yet ... for the estimated 20% of Americans that are considered obese. ... the Food and Drug Administration for its new wide bore ... The system is designed to meet growing demand for better ...
... Is your brand valuation worth a billion dollars today? Maybe yes ... At the end of the day, all the work you have ... and services in your marketplace adds up in an abstract space ... equity can be measured as a real, soft asset. It can ...
Cached Biology Technology:Republican sees nothing wrong with Doyle's use of executive order 2FDA okays new GE tomography system 2Is your brand worth billions? 2Is your brand worth billions? 3
(Date:7/9/2014)... from China challenges the commonly held belief that birds ... to fly. The birdlike fossil is actually not a ... of a tiny tree-climbing animal that could glide, say ... Blanding, Utah, and Alan Feduccia of the University of ... of Ornithology . , The fossil of the ...
(Date:7/9/2014)... measurement results accrue. To completely and systematically archive ... In fact, researchers in the life sciences spend ... to an online survey of 70 people working ... for Applied Information Technology FIT in Sankt Augustin. ... no centralized or structured approach to data collection ...
(Date:7/9/2014)... with high levels of vitamin D in their blood are ... , Patients with the highest levels of vitamin D have ... lowest levels, the findings reveal. , The study is the ... bowel cancer patients after their diagnosis which includes that ... sources with their long term survival prospects. , ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2Managing the data jungle 2Managing the data jungle 3
... to stop the spread of drug resistance in typhoid fever, ... published in the journal eLife . The ... bacteria can out-compete drug sensitive strains when grown in the ... is transmitted by consuming food or drink that is contaminated ...
... 9, 2013 /PRNewswire-iReach/ -- With the holiday season comes the ... American will put on up to five pounds in just ... CDC (Center for Disease Control) more than 65% of Americans ... obese. (Photo: http://photos.prnewswire.com/prnh/20131209/MN29878 ) ...
... inhibitors (SSRIs) are the most commonly prescribed antidepressants, but ... often try several different SSRI medications, each with a ... is effective. It takes three to four weeks to ... and their families continue to suffer. Now researchers ...
Cached Biology News:Antibiotic-resistant typhoid likely to spread despite drug control program 2HCG Injections and B12 shots now in stock at US Vitamin Injections Site 2A personal antidepressant for every genome 2A personal antidepressant for every genome 3
MAb to Desmoplakin I & II Desmoplakin I & II...
... in conjuction with Annexin V-FITC to distinguish ... of apoptosis (Annexin V positive, PI negative) ... of apoptosis or already dead (Annexin V-FITC ... the orange range of the spectrum using ...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... Sf9 Insect Cells are derived from the Spodoptera ... optimal growth, use in transfections, plaque assays, virus ... in a protocol that optimizes recovery of viable ... in serum-free BacVector Insect Cell Medium and can ...
Biology Products: